Significance of Programmed Cell Death Pathways in Neurodegenerative Diseases
International Journal of Molecular Sciences · 15.09.2024 · 25 (18) · 9947
DOI: 10.3390/ijms25189947 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.09.2024. Verfasst von Dong Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science, Fujian Normal University Qishan Campus, Fuzhou 350117, China. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Signal Transduction, Apoptosis. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 411 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joint Funds for the innovation of science and Technology, Fujian province.
Abstract (Originalsprache)
Programmed cell death (PCD) is a form of cell death distinct from accidental cell death (ACD) and is also referred to as regulated cell death (RCD). Typically, PCD signaling events are precisely regulated by various biomolecules in both spatial and temporal contexts to promote neuronal development, establish neural architecture, and shape the central nervous system (CNS), although the role of PCD extends beyond the CNS. Abnormalities in PCD signaling cascades contribute to the irreversible loss of neuronal cells and function, leading to the onset and progression of neurodegenerative diseases. In this review, we summarize the molecular processes and features of different modalities of PCD, including apoptosis, necroptosis, pyroptosis, ferroptosis, cuproptosis, and other novel forms of PCD, and their effects on the pathogenesis of neurodegenerative diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA), multiple sclerosis (MS), traumatic brain injury (TBI), and stroke. Additionally, we examine the key factors involved in these PCD signaling pathways and discuss the potential for their development as therapeutic targets and strategies. Therefore, therapeutic strategies targeting the inhibition or facilitation of PCD signaling pathways offer a promising approach for clinical applications in treating neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Life Science, Fujian Normal University Qishan Campus, Fuzhou 350117, China.
- Fujian Key Laboratory of Innate Immune Biology, Biomedical Research Center of South China, Fujian Normal University Qishan Campus, Fuzhou 350117, China.
ORCID-Profile: Dong Guo, Zhihao Liu, Jinglin Zhou, Daliang Li
Förderung
- Joint Funds for the innovation of science and Technology, Fujian province
Zitieren
APA
Guo, D., Liu, Z., Zhou, J., Ke, C., & Li, D. (2024). Significance of Programmed Cell Death Pathways in Neurodegenerative Diseases. International Journal of Molecular Sciences, 25(18), 9947. https://doi.org/10.3390/ijms25189947
Vancouver
Guo D, Liu Z, Zhou J, Ke C, Li D. Significance of Programmed Cell Death Pathways in Neurodegenerative Diseases. International Journal of Molecular Sciences. 2024;25(18):9947. doi:10.3390/ijms25189947
BibTeX
@article{Guo2024,
author = {Guo, Dong and Liu, Zhihao and Zhou, Jinglin and Ke, Chongrong and Li, Daliang},
title = {Significance of Programmed Cell Death Pathways in Neurodegenerative Diseases},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {18},
pages = {9947},
doi = {10.3390/ijms25189947}
}
EUVIMED